SEC Filing Form 4 for BIOLIFE SOLUTIONS INC

Rachel Ellingson, a director at BIOLIFE SOLUTIONS INC (BLFS), reported the disposition of 57,995 shares of common stock on October 6, 2026. This transaction was part of the merger between Bravo Merger Sub I, Inc. and BIOLIFE SOLUTIONS INC, as per the merger agreement dated July 21, 2026. Each share of common stock was converted into $11.25 in cash and 0.1442 shares of Repligen common stock. Following this transaction, Ellingson holds 0 shares of common stock. The filing is a Form 4, indicating a change in beneficial ownership.